Prof. dr Burçak Yılmaz je specijalista nuklearne medicine usmeren na radionuklidne terapije, PET-CT i PET-MRI snimanje i izveštavanje, kao i na konvencionalno snimanje u nuklearnoj medicini, uključujući SPECT/CT i ispitivanja gama kamerom. Diplomirala je kao najbolji đak generacije u koledžu Bahçeşehir, nakon čega je završila medicinsko obrazovanje i specijalizaciju na Klinici za nuklearnu medicinu Univerziteta u Istanbulu-Cerrahpaşa, gde je kasnije stekla doktorat iz nuklearne medicine, a zatim nastavila i doktorske studije iz molekularne onkologije na Univerzitetu zdravstvenih nauka. Njena karijera obuhvata opservacijski program na Univerzitetu u Vašingtonu i postdoktorsku stipendiju na Oregon Health and Science University, uz akademske i specijalističke funkcije u više turskih ustanova povezanih sa Univerzitetom zdravstvenih nauka i Univerzitetom Medipol, pre nego što se pridružila Bolnici Medicinskog fakulteta Univerziteta Biruni u zvanju vanrednog profesora. Njena istraživanja su se u velikoj meri bavila PSMA i FAPI PET/CT snimanjem u onkologiji, što je rezultiralo značajnim brojem međunarodnih recenziranih radova, uključujući radove objavljene u časopisu Journal of Nuclear Medicine. Članica je Turskog udruženja za nuklearnu medicinu, a 2017. godine dobila je Certificate of Merit Radiološkog društva Severne Amerike (RSNA).
Obrazovanje
-
Doktorat, nuklearna medicina
Univerzitet zdravstvenih nauka
2018–danas
-
Doktorat, nuklearna medicina
Univerzitet u Istanbulu-Cerrahpaşa
2012
-
Master studije (program medicine na engleskom jeziku)
Univerzitet u Istanbulu-Cerrahpaşa
2006
-
Najbolji đak generacije (prvi po rangu na završetku školovanja)
Koledž Bahçeşehir
2000
Akademske i administrativne funkcije
-
Vanredni profesor (nuklearna medicina)
Bolnica Medicinskog fakulteta Univerziteta Biruni
2025–danas
-
Postdoktorski istraživač
Oregon Health and Science University, Odeljenje za nuklearnu medicinu
2023–2024
-
Vanredni profesor (nuklearna medicina)
Bolnica Medipol Univerziteta Bahçelievler
2022–2023
-
Vanredni profesor (rukovodilac obuke i administracije)
Univerzitet zdravstvenih nauka, Gradska bolnica Başakşehir Çam ve Sakura, Klinika za nuklearnu medicinu
2020–2022
-
Vanredni profesor (nuklearna medicina)
Univerzitet zdravstvenih nauka, Istanbulska nastavno-istraživačka bolnica
2020
-
Lekar na opservacijskom programu
Univerzitet u Vašingtonu, Odeljenje za nuklearnu medicinu
2017
-
Lekar specijalista (nuklearna medicina)
Nastavno-istraživačke bolnice u sastavu Univerziteta zdravstvenih nauka (Istanbul)
2012–2020
-
Lekar na specijalizaciji
Univerzitet u Istanbulu-Cerrahpaşa, Klinika za nuklearnu medicinu
2007–2012
- Tursko udruženje za nuklearnu medicinu
-
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients
Annals of Nuclear Medicine · 2022 -
Tumor imaging with 68Ga-DOTA-FAPI-04 PET/CT: comparison with 18F-FDG PET/CT in 22 different cancer types
Clinical Nuclear Medicine · 2022 -
68Ga-DOTA-FAPI-04 PET/CT in neuroendocrine carcinoma of the liver with elevated AFP level: comparison with 18F-FDG PET/CT
Clinical Nuclear Medicine · 2022 -
Prediction of early biochemical response after 177Lu-PSMA radioligand therapy with 68Ga-PSMA PET: a different perspective with quantitative parameters
Nuclear Medicine Communications · 2022 -
Dual time point imaging of staging PSMA PET/CT quantification: spread and radiomic analyses
Annals of Nuclear Medicine · 2022 -
Tracheitis diagnosed with 68Ga-PSMA PET/CT in a patient with COVID-19
Clinical Nuclear Medicine · 2022 -
Adult tiger man: a case of dermatomyositis associated with thymoma
Clinical Nuclear Medicine · 2022 -
Effect of external cooling on 177Lu-PSMA uptake by parotid glands
Journal of Nuclear Medicine · 2019 -
The ability of pretreatment 18F-FDG PET/CT metabolic parameters for predicting axillary lymph node and distant metastasis and overall survival
Nuclear Medicine Communications · 2019 -
Comparison of preoperative locoregional 68Ga-PSMA-11 PET/CT and mp-MRI results with postoperative histopathology of prostate cancer
The Prostate · 2019 -
The efficacy of pretreatment and after-treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer
Nuclear Medicine Communications · 2019 -
PET/CT in the diagnosis and workup of sarcoidosis: focus on atypical manifestations
RadioGraphics · 2018 -
68Ga-PSMA-11 PET/CT in newly diagnosed prostate adenocarcinoma
Clinical Nuclear Medicine · 2018 -
Comparison of the prognostic value of 18F-FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
Brachytherapy · 2019 -
Comparison of day 3 and day 5 thyroglobulin results after Thyrogen injection in differentiated thyroid cancer patients
Therapeutic Advances in Endocrinology and Metabolism · 2018 -
Diagnostic value of 18F-FDG PET/CT in patients with spondylodiscitis: is dual time point imaging time worthy?
Diagnostic Microbiology and Infectious Disease · 2016 -
False-positive 68Ga-DOTATATE PET/CT in active chronic prostatitis
Clinical Nuclear Medicine · 2019 -
Subacute venous infarct mimicking cerebral metastasis in 18F-FDG PET/CT
Clinical Nuclear Medicine · 2019 -
Misleading 18F-FDG PET/CT finding caused by chronic HIV infection in a patient with gastric carcinoma: a case report
International Journal of STD & AIDS · 2018 -
Lacrimal gland uptake on 18F-florbetapir amyloid positron emission tomography scan
Radiology Case Reports · 2017 -
Surgical approach to anorectal melanoma with PET-CT staging: a case report
The Surgery Journal · 2017 -
Parasitic infestation mimicking hepatic metastasis with four different imaging modalities in a patient with breast carcinoma
The Breast Journal · 2017 -
Clinical, pathological and 18F-FDG PET/CT findings in synchronous primary vaginal and endometrial cancers
Hellenic Journal of Nuclear Medicine · 2016 -
Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma
Nuklearmedizin · 2023 -
Radiation-induced secondary lung cancer detected with 18F-FDG PET/CT 20 years after radiotherapy of breast cancer
SM Journal of Biomedical Engineering · 2017 -
Primary isolated breast lymphoma presenting as primary breast cancer with 18F-FDG PET/CT
Molecular Imaging and Radionuclide Therapy · 2023 -
Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule
npj Precision Oncology · 2024 -
Theranostics in neuroendocrine tumors: updates and emerging technologies
Current Problems in Cancer · 2024 -
The evaluation of external dose rate measurements of patients during and after 18F-FDG PET/CT imaging and appropriate discharge time from the PET/CT department
İstanbul Tıp Dergisi · 2019 -
The effect of transarterial Y-90 microsphere treatment of liver tumors on biochemical parameters
İstanbul Tıp Dergisi · 2019 -
Diagnostic accuracy of preoperative metabolic 18F-FDG PET/CT parameters for patients with endometrial cancer treated with postoperative radiation therapy
Çam and Sakura Medical Journal · 2021 -
Regression of hypermetabolic splenic granulomata mimicking metastases following non-targeted effect of radiotherapy for uterine cervical carcinoma
Çam and Sakura Medical Journal · 2021 -
Prognostic role of interleukin-23 in prostate adenocarcinoma: comparison with 68Ga-PSMA-11 PET/CT findings
İstanbul Tıp Dergisi · 2021 -
Diffuse bone marrow involvement of Langerhans cell histiocytosis detected with 18F-FDG PET/CT
Çam and Sakura Medical Journal · 2022
-
Certificate of Merit
Radiološko društvo Severne Amerike (RSNA), SAD
2017
-
Najbolji sažetak lekara na specijalizaciji
Western Regional Chapter of Society of Nuclear Medicine and Molecular Imaging, Vankuver, Kanada
2023
Nuklearna medicina
Medicinski centri ovog odeljenja
Tretmani ovog odeljenja
13- Aktinijum-225 PSMA terapija - Ac-225 PSMA lečenje
- DaTscan
- Dotatate PET/CT snimanje - snimanje neuroendokrinih tumora
- Ga-68 FAPI PET
- I-131 MIBG terapija - lečenje radioaktivnim MIBG-om
- Lu-177 PSMA terapija - lečenje lutecijumom PSMA
- MIBG scintigrafija - snimanje metajodbenzilgvanidinom
- PET/CT snimanje - pozitronska emisiona tomografija
- PRRT terapija - peptidna receptorska radionuklidna terapija
- PSMA PET/CT snimanje - dijagnostika karcinoma prostate
- Scintigrafija kostiju
- Snimanje štitaste žlezde - scintigrafija štitaste žlezde
- Terapija radioaktivnim jodom - lečenje I-131